| Medication Name | Verdeso Foam |
| Generic Name | Desonide |
| Purpose | Treats inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. |
| Mechanism of Action | Acts as a topical corticosteroid, reducing inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability. |
| Dosage Forms | Topical foam |
| Available Strengths | 0.05% |
| Dosage Frequency | Apply to affected area twice daily, or as directed by a healthcare provider. |
| Common Side Effects | Burning, itching, irritation, dryness, folliculitis, acneiform eruptions, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria. |
| Serious Side Effects | Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome, hyperglycemia, glucosuria, local hypersensitivity reactions. |
| Drug Interactions | No significant drug interactions reported; use caution with other topical medications. |
| Important Notes | Avoid contact with eyes. Do not use on the face, groin, or axillae unless directed by a physician. Prolonged use may cause HPA axis suppression. |
| Storage | Store at controlled room temperature 68° to 77°F (20° to 25°C). Contents are under pressure. Do not puncture or incinerate. Do not expose to heat or store at temperatures above 120°F (49°C). |
| Missed Dose | Apply as soon as you remember. If it is almost time for your next dose, skip the missed dose and apply the medication at the next regularly scheduled time. Do not apply a double dose. |
| Alternatives | Hydrocortisone, Triamcinolone, Clobetasol (for more severe conditions) |